Authors/Disclosures
|
Kathleen E. Clarence-Smith, MD, PhD, FAAN
(KM Pharmaceuticals Consulting)
|
Dr. Clarence-Smith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Riverside Pharmaceutical Corporation. Dr. Clarence-Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for KMPHC. Dr. Clarence-Smith has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Chase Therapeutics Corporation. Dr. Clarence-Smith has received stock or an ownership interest from Chase Therapeutics Corporation. Dr. Clarence-Smith has received stock or an ownership interest from Riverside Pharmaceuticals Corporation. |
|
Vivienne Shen
|
Vivienne Shen has received personal compensation for serving as an employee of Lundbeck. |
|
Christine B. Hunter, RN, BSN
(PDCMDC)
|
No disclosure on file |
|
Joseph Jankovic, MD, FAAN
(Baylor College of Medicine)
|
Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Motric Bio. Dr. Jankovic has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Jankovic has received research support from Michael J Fox Foundation for Parkinson Research;. The institution of Dr. Jankovic has received research support from Dystonia Coalition. The institution of Dr. Jankovic has received research support from Parkinson's Foundation. |
|
Lara W. Katzin, MD
(Colorado Permanente Medical Group)
|
Dr. Katzin has nothing to disclose. |